Skip NavigationSkip to Content

Cockroach allergen Bla g 2: An unusual aspartic proteinase

  1. Author:
    Wunschmann, S.
    Gustchina, A.
    Chapman, M. D.
    Pomes, A.
  2. Author Address

    INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA. NCI, Frederick, MD 21701 USA Wunschmann, S, INDOOR Biotechnol Inc, 1216 Harris St, Charlottesville, VA 22903 USA
    1. Year: 2005
    2. Date: JUL
  1. Journal: Journal of Allergy and Clinical Immunology
    1. 116
    2. 1
    3. Pages: 140-145
  2. Type of Article: Article
  1. Abstract:

    Background: Enzymatic activity of mite, fungal, and bee venom allergens is thought to potentiate their allergenicity. Bla g 2 is a potent cockroach allergen, but despite sharing sequence homology with aspartic proteinases, it contains critical amino acid substitutions that impair proteolytic activity. The biologic function of Bla g 2 remains unclear.Objective: We sought to investigate the effects of specific amino acid substitutions on enzymatic activity, and the peptide-binding capability of Bla g 2.Methods: Site-directed mutagenesis was used to produce a recombinant Bla g 2 mutant (Mut) with corrected canonical triads and a flap region. Another mutant (MutF(-)) was expressed after additional mutations in the flap region of Mut. Bla g 2 wild-type (Wt), Mut, and MutF(-) were assayed for aspartic proteinase activity, and Bla g 2 Wt was tested for pepstatin binding.Results: Recombinant Bla g 2 Wit and Mut did not show enzymatic activity in a milk-clotting and hemoglobin assay. By using a modified hemoglobin assay, residual activity inhibited by pepstatin was detected for MutF(-) and Wt at 20 mu g/mL, whereas pepsin was active at a 1000-fold lower concentration. Most of Bla g 2 binding to pepstatin-agarose was nonspecific.Conclusion: Residual proteolytic activity was found for Bla g 2 at concentrations of approximately 4 mM. This weak activity suggests that proteolysis is not the primary function of this allergen and that it is unlikely to contribute to the allergenicity of Bla g 2. Bla g 2 has a cleft that might specifically bind ligands other than pepstatin

    See More

External Sources

  1. DOI: 10.1016/j.jaci.2005.04.024
  2. No sources found.

Library Notes

  1. No notes added.
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel